Brainstorm Cell Therapeutics Shares Are Trading Lower After the Company Announced It Received a Letter From the Nasdaq Indicating That It Did Not Regain Compliance With the Minimum Bid Price Requirement
Brainstorm Cell Therapeutics宣布收到纳斯达克的一封信表明其没有恢复遵守最低出价要求后，该公司股价走低